Tirzepatide

Tirzepatide is a next-generation injectable medicine used in the treatment of type 2 diabetes mellitus. It is the first medication that works on both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, helping achieve superior blood sugar control and improved metabolic health.

Tirzepatide helps the body release insulin when blood sugar levels are high, reduces excess glucagon secretion, slows gastric emptying, and decreases appetite. These combined actions result in better glycaemic control, improved insulin sensitivity, and significant weight reduction in many patients when used along with a healthy diet and exercise.